2014 Venture Kick winner PB&B raises CHF 2 million

03.05.2016

The Lausanne based MedTech startup, PB&B, focusing on making Aesthetics and Plastic Surgery procedures natural and minimally invasive, announced that it has raised CHF 2 million from a strategic investor in April 2016.

anthony-aho-crm.jpg
Anthony Aho, CEO and co-founder of PB&B (credits www.pbbtech.ch)

PB&B, winner of Venture Kick in 2014, has raised 2 million Swiss Francs. “It is an equity investment of a single strategic investor”, explained CEO and co-founder Anthony Aho.

The funds will be used to fund on-going R&D testing and development, in the view of launching a first clinical study by Q2-2017. Since 2014, pre-clinical studies have been conducted in collaboration with scientists and doctors from EPFL and HUG (University Hospitals of Geneva).

The company has positioned itself as a novel remodeling injection in the market of fillers and fat transfer procedures, through implementation of a market entry strategy directed towards anti-aging and facial rejuvenation of the mid-facial area. The “PB&B Technology” uses biodegradable microspheres that are loaded with lipids and later injected into the skin in a controlled manner to increase the volume of fat tissues. As a result, the process directs the patient's own tissues to naturally rejuvenate the face and diminish any wrinkles for a period of up to 20 months on average; longer than with any dermal filler.

About PB&B
PB&B was founded in 2013 in Ecublens, Lausanne by a group of bioengineers who are working together with Swiss academic institutes and doctors to develop their technology and products. Their passion for Aesthetics has enabled them to win a number of awards including Venture Kick, venture leaders, HUG Innovation Trophy 2014 and they have also been nominated in several others internationally.

(source: startupticker.ch)

Additional Links